A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
Clinical trial NCT04592419 · COMPLETED
Trial details
- NCT number
- NCT04592419
- Sponsor
- Kodiak Sciences Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2022-06-10
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.